Investing.com - Stifel resumed coverage of Beta Bionics, Inc. (NASDAQ:BBNX) with a Buy rating and a price target of $26.00 on Monday. Currently trading at $20.24, the stock sits within analysts’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback